Results of the Two-County trial of mammography screening are not compatible with contemporaneous official Swedish breast cancer statistics

Danish Medical Bulletin

Volumn 53, Issue 4, 2006, Pages 438-439

  Zahl, Per Henrik ^a   Gøtzsche, Peter C ^b   Andersen, Jannike Mørch ^a,c   Mæhlen, Jan ^c  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CANCER STATISTICS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; RISK REDUCTION; SWEDEN;

EID: 33751188638     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Tabár L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;325:829-32.
2. Gøtzsche PC, Mæhlen J, Zahl PH. What is publication? Editorial conflict over screening mammography. Lancet 2006:368 (Nov 25) (In press).
3. Gøtzsche PC. On the benefits and harms of screening for breast cancer. Int J Epidemiol 2004;33:56-64.
4. Tabar L, Fagerberg G, Duffy SW, Day NE, Cad A, Gröntoft O. Update of the Swedish Two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-210.
5. Nyström L. Rutquist LE, Wall S, et al. Breast cancer screening with mammography: overview of the Swedish randomised trials. Lancet 1993;341:973-8.
6. Zahl PH, Mæhien J. Overdlagnosis in mammography screening. Tidsskr Nor Laegeforen 2004;124:2238-9.
7. Nyström L, Andresson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqulst LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-19.
8. Tabar L, Vitak B, Chen HH et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 2000;38:625-51.
9. Crewdson J. Swedes doubt mammography trial: disparities found in landmark study. Chicago Tribune 2002; March 15. www.chicagotribune.com/ news/chi-0203150264mar15.story (accessed 15 March, 2002).
10. Vainio H, Bianchini F. IARC Handbooks of Cancer Prevention. Vol 7: Breast Cancer Screening. IARC Press; Lyon 2002.
11. Tabár L, Smith RA, Duffy SW. Update on effects of screening mammography. Lancet 2002:360:337.
12. Nyström L, Andersson I, Bjurstam N, Frisell J, Rutqvist LE. Update on effects of screening mammography (authors' reply). Lancet 2002;360:339-40.
13. Woodman CBJ, Threlfall AG. Boggis CRM, Prior P. Is the three year breast screening interval too long? Occurrence of Interval cancers in NHS breast screening programme's north western region. BMJ 1995;310:224-6.
14. Cancer incidence in Sweden 1984. Stockholm: National Board of Health and Welfare (Socialstyrelsen), 1987.
15. Dödsorsaker 1984. Stockholm: National Board of Health and Welfare (Socialstyrelsen), 1986.